WHY CHOOSE KESIMPTA
*Once monthly after 3 weekly starter doses.
SEE WHY ZENOVIA & ANDY CHOSE KESIMPTA FOR RMS
Designed to Be Different
KESIMPTA is the only B-cell treatment you can take once a month* from the comfort of home. It offers a powerful combination of benefits to help you manage your relapsing MS.
Check out the powerful results† of KESIMPTA
Review the proven safety profile‡
Learn about once-a-month* treatment with a prefilled auto‑injector pen
Considering KESIMPTA?
You can take an active role in choosing your RMS treatment. Use this guide to get prepared with the right questions to ask your doctor.
3 REASONS TO CHOOSE THE KESIMPTA AUTO‑INJECTOR PEN
WALT D.
Dad, Engineer
Chose KESIMPTA as 1st treatment: 2021
“KESIMPTA gives me the results I’m looking for, plus the at-home flexibility is fantastic. It checks all the boxes for me.”
RACHEL W.
Avid Traveler, Dog Lover
Switched to KESIMPTA: 2020
“The Alongside™ KESIMPTA Support Program connected me with my dedicated coordinator for one-on-one help. They helped me feel personally cared for and more confident using the auto-injector pen.”
Check out the proven results
Watch how to use the pen step-by-step
Want more information to help you decide?
Find out why so many people are choosing KESIMPTA.
Want co-pay help?
97% of all prescriptions filled have a $0 out of pocket cost when used with the Access Card§‖ from the Alongside™ KESIMPTA Patient Support Program.
MS, multiple sclerosis; RMS, relapsing multiple sclerosis.
*Once monthly after 3 weekly starter doses.
†Proven to reduce relapses and disability progression in 2 studies vs teriflunomide.
‡In 2 studies vs teriflunomide.
§Limitations apply. Offer not valid under Medicare, Medicaid, or any other federal or state health insurance program. Patients with commercial insurance who are initially denied coverage may receive free KESIMPTA for up to 12 months while seeking coverage. Patients with commercial insurance who have coverage for KESIMPTA may receive up to $18,000 in annual co-pay benefits. Novartis reserves the right to rescind, revoke, or amend this program without notice. Additional limitations may apply. See complete Terms & Conditions at start.kesimpta.com.
‖2023 data on file.